Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
0.8920
+0.0020 (0.22%)
At close: Aug 14, 2026, 4:00 PM EDT
0.9000
+0.0080 (0.90%)
After-hours: Aug 14, 2026, 7:34 PM EDT
Nautilus Biotechnology Market Cap
Nautilus Biotechnology has a market cap or net worth of $113.51 million as of August 14, 2026. Its market cap has increased by 25.66% in one year.
Market Cap
113.51M
Enterprise Value
57.30M
1-Year Change
25.66%
Ranking
Category
Stock Price
$0.89
ChartMarket Cap Chart
Since March 26, 2021, Nautilus Biotechnology's market cap has decreased from $117.04M to $113.51M, a decrease of -3.01%. That is a compound annual growth rate of -0.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 113.51M | -53.91% |
| Dec 31, 2025 | 246.29M | 16.76% |
| Dec 31, 2024 | 210.95M | -43.54% |
| Dec 29, 2023 | 373.66M | 66.44% |
| Dec 30, 2022 | 224.50M | -65.10% |
| Dec 31, 2021 | 643.18M | 449.56% |
| Mar 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vivani Medical | 120.73M |
| Inovio Pharmaceuticals | 119.51M |
| Yarrow Bioscience | 118.97M |
| Black Diamond Therapeutics | 116.06M |
| Seer, Inc. | 115.06M |
| enGene Therapeutics | 113.88M |
| Coya Therapeutics | 112.36M |
| NeOnc Technologies Holdings | 109.44M |